Professor Maggie Shepherd - impact of a genetic diabetes diagnosis on patients and their families
Precision diagnosis
Precision diagnosis
Getting the right diagnosis as early as possible is crucial to optimising treatment and management of diabetes. The Exeter team has been at the forefront of a paradigm shift in diabetes diagnosis worldwide over the past ten years, with genetic diagnosis now standard for monogenic sub types. Funded by the Wellcome Trust, the team offers free genetic testing to babies with neonatal diabetes worldwide.
The team is also revolutionising diagnosis in clinics worldwide. Their research has established that misdiagnosis is common, and they are expanding knowledge on the complexities between type 1 and type 2 diabetes. Now, they are creating an app and a clinical calculator to help health professionals make the right diagnosis to improve lives.
Precision diagnosis - primary investigators
| Name | Role | Keywords |
|---|---|---|
| NIHR Clinician Scientist | Type1, Type 2, insulin, c-peptide, classification, biomarkers, diagnosis, hypoglycaemia | |
|
|
NIHR Clinical Scientist | Monogenic diabetes, insulin production, c-peptide, creatinine, type 2, glycaemic deterioration, biomarkers, genetics |
| Honorary Clinical Professor | Monogenetic diabetes, genetics, misdiagnosis, patient experience, type 1, type 2, c-peptide, clinical care | |
| Harry Keen Research Fellow | β cells, Type 1 diabetes, C-peptide, translational research, autoantibodies, autoimmune disease, Type 1 diabetes, Genetic risk score, T1D GRS, Extremely early onset type 1 diabetes | |
|
Senior Lecturer in Medical Statistics |
||
|
Senior Lecturer (E&R) |
Microvascular Complications, Ophthalmic markers, Early Diagnosis, Screening , Implementation, Neurodegenerative biomarkers |